Integrated solution combining Circulating Tumor Cells (CTC) enrichment and sequencing sample preparation in a single device
Parithera has raised €97k across 1 funding round from 1 investor, most recently a Debt round in Mar 2022. Based in Épalinges, Switzerland; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-03-22 | Debt | €97k |
| Foundation for Technological Innovation (FIT) |
| View deal → |
